Metropolis Healthcare rises on higher quarterly revenue

Dr. Lal PathLabs

07/10/2025 05:20

Oct 7 (Reuters) -

** Shares of Metropolis Healthcare METP.NS rise 2.7% to 2,127.80 rupees

** Co reports 23% Y/Y climb in September quarter consolidated revenue

** Stock rated "buy" on avg by 16 analysts; median PT at 2,240 rupees - data compiled by LSEG

** YTD, stock up 2.5% vs larger rival Dr Lal Path Labs' DLPA.NS nearly 6% climb

 (Reporting by Mridula Kumar)

 ((Mridula.Kumar@thomsonreuters.com;))